Get started
Author

Line K. Vibholm

Observed names: L Vibholm, Line K Vibholm, Line Khalidan Vibholm, Line Vibholm, Vibholm, Line Khalidan
ORCID: 0000-0001-8945-1905
Observed ORCID: 0000-0001-8945-1905
OpenAlex ID: A5031584885
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection
2017 · Line Vibholm, Mariane H. Schleimann, et al. · Clinical Infectious Diseases · 153
PDF
SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses
2021 · Line K. Vibholm, Stine S.F. Nielsen, et al. · EBioMedicine · 142
PDF
Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial
2023 · Jesper D. Gunst, Jesper F. Højen, et al. · Nature Medicine · 95
PDF
Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1+ individuals
2019 · Line K. Vibholm, Christina V. Konrad, et al. · AIDS · 89
SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity
2021 · Stine SF Nielsen, Line K Vibholm, et al. · EBioMedicine · 76
PDF
Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption
2019 · Line K. Vibholm, Julio C.C. Lorenzi, et al. · Journal of Virology · 67
PDF
Coenzyme Q10 as Treatment of Post COVID-19 Condition
2022 · Kristoffer S. Hansen, Trine H. Mogensen, et al. · The Lancet Regional Health - Europe · 56
PDF
The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon
2017 · A R Krarup, M Abdel-Mohsen, et al. · Mucosal Immunology · 40
PDF
TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes
2019 · Mariane H. Schleimann, Maria-Louise Kobberø, et al. · EBioMedicine · 38
Myopathy as a cause of Long COVID fatigue: Evidence from quantitative and single fiber EMG and muscle histopathology
2023 · Jane Agergaard, Benjamin Yamin Ali Khan, et al. · Clinical Neurophysiology · 34
Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution
2021 · Ida Monrad, Signe Risgaard Sahlertz, et al. · Open Forum Infectious Diseases · 29
PDF
Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study
2023 · Astrid Korning Hvidt, Huaijian Guo, et al. · BMC Immunology · 21
PDF
Antiviral and Immunological Effects of Tenofovir Microbicide in Vaginal Herpes Simplex Virus 2 Infection
2012 · Line Vibholm, Line S. Reinert, et al. · AIDS Research and Human Retroviruses · 19
Examination of autoantibodies to type I interferon in patients suffering from long COVID
2023 · Kristoffer Skaalum Hansen, Sofie Eg Jørgensen, et al. · Journal of Medical Virology · 18
PDF
Single cell analysis reveals a subset of cytotoxic-like plasmacytoid dendritic cells in people with HIV-1
2023 · Lamin B. Cham, Jesper D. Gunst, et al. · iScience · 15
CD169 (Siglec-1) as a Robust Human Cell Biomarker of Toll-Like Receptor 9 Agonist Immunotherapy
2022 · Stine Sofie Frank Lende, Marie Høst Pahus, et al. · Frontiers in Cellular and Infection Microbiology · 7
The Impact of IFNλ4 on the Adaptive Immune Response to SARS-CoV-2 Infection
2021 · Michelle Møhlenberg, Ida Monrad, et al. · Journal of Interferon & Cytokine Research · 3
Immunological dysfunction associated with SARS-CoV-2 persistence in immunocompromised patients
2026 · Ida M Johannsen, Line K Vibholm, et al. · Clinical & Experimental Immunology · 1
Behandling af HIV-inficerede patienter med TLR9-immunterapi inducerer HIV-specifikt immunrespons
2020 · Konrad, Christina Valbirk, Vibholm, Line Khalidan, et al.
Works count: 28
Citation count: 903
H-index: 15
I10-index: 15
Year
Topic
Type